Artivion, Inc. CYL.F Stock
Artivion, Inc. Price Chart
Artivion, Inc. CYL.F Financial and Trading Overview
Artivion, Inc. stock price | 19.86 EUR |
Previous Close | 14.6 EUR |
Open | 14.4 EUR |
Bid | 14.4 EUR x 180000 |
Ask | 14.5 EUR x 180000 |
Day's Range | 14.4 - 14.4 EUR |
52 Week Range | 10.1 - 23 EUR |
Volume | 300 EUR |
Avg. Volume | 87 EUR |
Market Cap | 591.33M EUR |
Beta (5Y Monthly) | 1.410626 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 9, 2015 |
1y Target Est | 34.19 EUR |
CYL.F Valuation Measures
Enterprise Value | 909.92M EUR |
Trailing P/E | N/A |
Forward P/E | 240 |
PEG Ratio (5 yr expected) | -82.65 |
Price/Sales (ttm) | 1.8490382 |
Price/Book (mrq) | 2.1031108 |
Enterprise Value/Revenue | 2.845 |
Enterprise Value/EBITDA | 23.574 |
Trading Information
Artivion, Inc. Stock Price History
Beta (5Y Monthly) | 1.410626 |
52-Week Change | -3.87% |
S&P500 52-Week Change | 20.43% |
52 Week High | 23 EUR |
52 Week Low | 10.1 EUR |
50-Day Moving Average | 12.98 EUR |
200-Day Moving Average | 13.17 EUR |
CYL.F Share Statistics
Avg. Volume (3 month) | 87 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 40.88M |
Float | 36.68M |
Short Ratio | N/A |
% Held by Insiders | 4.62% |
% Held by Institutions | 87.14% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -9.17% |
Operating Margin (ttm) | 5.09% |
Gross Margin | 64.26% |
EBITDA Margin | 12.06% |
Management Effectiveness
Return on Assets (ttm) | 1.32% |
Return on Equity (ttm) | -10.16% |
Income Statement
Revenue (ttm) | 319.8M EUR |
Revenue Per Share (ttm) | 7.96 EUR |
Quarterly Revenue Growth (yoy) | 7.79% |
Gross Profit (ttm) | 202.52M EUR |
EBITDA | 38.6M EUR |
Net Income Avi to Common (ttm) | -29195000 EUR |
Diluted EPS (ttm) | -0.66 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 30.77M EUR |
Total Cash Per Share (mrq) | 0.75 EUR |
Total Debt (mrq) | 356.18M EUR |
Total Debt/Equity (mrq) | 127.25 EUR |
Current Ratio (mrq) | 5.475 |
Book Value Per Share (mrq) | 6.847 |
Cash Flow Statement
Operating Cash Flow (ttm) | -10709000 EUR |
Levered Free Cash Flow (ttm) | 6.09M EUR |
Profile of Artivion, Inc.
Country | Germany |
State | GA |
City | Kennesaw |
Address | 1655 Roberts Boulevard N.W. |
ZIP | 30144 |
Phone | 770 419 3355 |
Website | https://artivion.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 1300 |
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent and graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Q&A For Artivion, Inc. Stock
What is a current CYL.F stock price?
Artivion, Inc. CYL.F stock price today per share is 19.86 EUR.
How to purchase Artivion, Inc. stock?
You can buy CYL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Artivion, Inc.?
The stock symbol or ticker of Artivion, Inc. is CYL.F.
Which industry does the Artivion, Inc. company belong to?
The Artivion, Inc. industry is Medical Devices.
How many shares does Artivion, Inc. have in circulation?
The max supply of Artivion, Inc. shares is 41.71M.
What is Artivion, Inc. Price to Earnings Ratio (PE Ratio)?
Artivion, Inc. PE Ratio is now.
What was Artivion, Inc. earnings per share over the trailing 12 months (TTM)?
Artivion, Inc. EPS is -0.7 EUR over the trailing 12 months.
Which sector does the Artivion, Inc. company belong to?
The Artivion, Inc. sector is Healthcare.